KZRKezar Life Sciences Inc
$7.29
$0.07
(0.95%)
Closed $7.29
$0.08
(1.10%)
After Hours
EarningsAug 12
Mkt Cap$53.86M
Vol616,015.00
Fundamentals
Mkt Cap
$53.86M
Volume
-
52W High
$7.55
52W Low
$3.53
PE Ratio
-1.18
Avg. Volume
56,214.15
EPS (Annual)
-$7.66
Rev/Employee
$0.00
Earnings
Aug 12
Kezar Life Sciences (KZR) Expected to Announce Earnings on Tuesday
Kezar Life Sciences (NASDAQ:KZR) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at...
MarketBeat
Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by Analysts
Shares of Kezar Life Sciences, Inc. (NASDAQ:KZR - Get Free Report) have earned a consensus rating of "Reduce" from the six analysts that are presently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a sell recommendation and four have issued a hold...
MarketBeat
Kezar Life Sciences, Inc. (NASDAQ:KZR) Sees Large Decrease in Short Interest
Kezar Life Sciences, Inc. (NASDAQ:KZR - Get Free Report) was the recipient of a large decline in short interest during the month of April. As of April 15th, there was short interest totaling 151,602 shares, a decline of 24.7% from the March 31st total of 201,330 shares. Based on an average daily...
MarketBeat
Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?
Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 14, 2026 Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may...
PR Newswire
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 10, 2026 Insiders may stand to receive...
PR Newswire
Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Average Recommendation of "Reduce" by Brokerages
Kezar Life Sciences, Inc. (NASDAQ:KZR - Get Free Report) has been given an average recommendation of "Reduce" by the six ratings firms that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating and four have assigned a hold rating to the...
MarketBeat
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS...
PR Newswire
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders?
Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, April 7, 2026 Insiders may stand to receive...
PR Newswire
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders?
Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders? Are KZR, NSA, EQH, CTRA Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, March 31, 2026 Insiders may stand to...
PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR) $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar...
PR Newswire
<
1
2
...
>